Telix Pharmaceuticals Limited (TLX) Increases R&D by 47%, Progresses Key Prostate and Brain Cancer Trials

18 9 月, 2025

One Min Read

18 Views

原文: https://finance.yahoo.com/news/telix-pharmaceuticals-limited-tlx-increases-144006500.html

Last Update: 18 9 月, 2025

Written By

Other Articles

Previous

Prestige Consumer Healthcare Inc. (PBH) Moves to Stabilize Eye Care Amid 2025 Headwinds

Next

Qiagen N.V. (QGEN) Rolls Out QIAstat-Dx Rise, Expands U.S. Testing Access

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept